What is the analyst consensus rating for INCY?

The analyst consensus rating for INCY is "Hold" based on 19 analyst recommendations.

What is the average price target for INCY?

The average 12-month price target for INCY is $106.61, representing an upside of 11.1% from the current price of $95.93.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Incyte Corporation (INCY) Forecast: Analyst Ratings & Targets

Latest INCY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Mar 30, 2026	Mitchell S. Kapoor	HC Wainwright	Reiterates	Strong Buy	$135.00 → $135.00 +0.00 (0.0%)
Mar 26, 2026	PerPlexity Biotechnology	TipRanks - PerPlexity	Reiterates	Buy	$112.00 → $105.00 -7.00 (-6.3%)
Mar 26, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Buy	$109.00 → $103.00 -6.00 (-5.5%)
Mar 25, 2026	Mitchell S. Kapoor	HC Wainwright	Reiterates	Strong Buy	$135.00 → $135.00 +0.00 (0.0%)
Mar 25, 2026	Etzer Darout	Barclays	Maintains	Buy	$117.00
Mar 25, 2026	Ashwani Verma	UBS	Maintains	Hold	$104.00 → $94.00 -10.00 (-9.6%)
Mar 23, 2026	Evan Seigerman	BMO Capital	Maintains	Sell	$75.00
Mar 18, 2026	Srikripa Devarakonda	Truist	Maintains	Hold	-
Mar 16, 2026	Faisal Khurshid	Jefferies	Downgrades	Hold	$120.00 → $94.00 -26.00 (-21.7%)
Mar 9, 2026	Mitchell S. Kapoor	HC Wainwright	Reiterates	Strong Buy	$135.00 → $135.00 +0.00 (0.0%)
Mar 5, 2026	Maneka Mirchandaney	Evercore ISI Group	Maintains	Hold	$73.00 → $110.00 +37.00 (50.7%)
Feb 18, 2026	Etzer Darout	Barclays	Maintains	Buy	$116.00 → $117.00 +1.00 (0.9%)
Feb 11, 2026	Mitchell S. Kapoor	HC Wainwright	Reiterates	Strong Buy	$135.00 → $135.00 +0.00 (0.0%)
Feb 11, 2026	Stephen Willey	Stifel	Maintains	Strong Buy	$119.00 → $120.00 +1.00 (0.8%)
Feb 11, 2026	Clara Dong	Jefferies	Maintains	Buy	$120.00
Feb 11, 2026	Salveen Richter	Goldman Sachs	Maintains	Hold	$90.00 → $98.00 +8.00 (8.9%)
Feb 11, 2026	Derek Archila	Wells Fargo	Maintains	Hold	$107.00 → $101.00 -6.00 (-5.6%)
Feb 11, 2026	Brian Abrahams	RBC Capital	Maintains	Hold	$95.00 → $92.00 -3.00 (-3.2%)
Feb 11, 2026	Judah Frommer	Morgan Stanley	Maintains	Hold	$94.00 → $102.00 +8.00 (8.5%)
Feb 10, 2026	Tazeen Ahmad	BofA Securities	Reiterates	Buy	$118.00 → $121.00 +3.00 (2.5%)
Feb 10, 2026	Brian Abrahams	RBC Capital	Maintains	Hold	$95.00 → $92.00 -3.00 (-3.2%)
Feb 6, 2026	Allison Bratzel	Piper Sandler	Maintains	Buy	$102.00 → $110.00 +8.00 (7.8%)
Feb 5, 2026	Mitchell S. Kapoor	HC Wainwright	Initiates	Strong Buy	$135.00
Feb 4, 2026	Etzer Darout	Barclays	Maintains	Buy	$115.00 → $116.00 +1.00 (0.9%)
Jan 20, 2026	Derek Archila	Wells Fargo	Downgrades	Hold	$116.00 → $107.00 -9.00 (-7.8%)
Jan 13, 2026	Marc Frahm	TD Cowen	Maintains	Strong Buy	$101.00 → $128.00 +27.00 (26.7%)
Jan 6, 2026	Vikram Purohit	Morgan Stanley	Maintains	Hold	$92.00 → $94.00 +2.00 (2.2%)

Mitchell S. Kapoor

HC Wainwright

Strong BuyReiterates

$135.00 → $135.00

Mar 30

PerPlexity Biotechnology

TipRanks - PerPlexity

BuyReiterates

$112.00 → $105.00

Mar 26

OpenAI Biotechnology

TipRanks - OpenAI

BuyReiterates

$109.00 → $103.00

Mar 26

Mitchell S. Kapoor

HC Wainwright

Strong BuyReiterates

$135.00 → $135.00

Mar 25

Etzer Darout

Barclays

BuyMaintains

$117.00

Mar 25

Ashwani Verma

UBS

HoldMaintains

$104.00 → $94.00

Mar 25

Evan Seigerman

BMO Capital

SellMaintains

$75.00

Mar 23

Srikripa Devarakonda

Truist

HoldMaintains

Mar 18

Faisal Khurshid

Jefferies

HoldDowngrades

$120.00 → $94.00

Mar 16

Mitchell S. Kapoor

HC Wainwright

Strong BuyReiterates

$135.00 → $135.00

Mar 9

Maneka Mirchandaney

Evercore ISI Group

HoldMaintains

$73.00 → $110.00

Mar 5

Etzer Darout

Barclays

BuyMaintains

$116.00 → $117.00

Feb 18

Mitchell S. Kapoor

HC Wainwright

Strong BuyReiterates

$135.00 → $135.00

Feb 11

Stephen Willey

Stifel

Strong BuyMaintains

$119.00 → $120.00

Feb 11

Clara Dong

Jefferies

BuyMaintains

$120.00

Feb 11

Salveen Richter

Goldman Sachs

HoldMaintains

$90.00 → $98.00

Feb 11

Derek Archila

Wells Fargo

HoldMaintains

$107.00 → $101.00

Feb 11

Brian Abrahams

RBC Capital

HoldMaintains

$95.00 → $92.00

Feb 11

Judah Frommer

Morgan Stanley

HoldMaintains

$94.00 → $102.00

Feb 11

Tazeen Ahmad

BofA Securities

BuyReiterates

$118.00 → $121.00

Feb 10

Brian Abrahams

RBC Capital

HoldMaintains

$95.00 → $92.00

Feb 10

Allison Bratzel

Piper Sandler

BuyMaintains

$102.00 → $110.00

Feb 6

Mitchell S. Kapoor

HC Wainwright

Strong BuyInitiates

$135.00

Feb 5

Etzer Darout

Barclays

BuyMaintains

$115.00 → $116.00

Feb 4

Derek Archila

Wells Fargo

HoldDowngrades

$116.00 → $107.00

Jan 20

Marc Frahm

TD Cowen

Strong BuyMaintains

$101.00 → $128.00

Jan 13

Vikram Purohit

Morgan Stanley

HoldMaintains

$92.00 → $94.00

Jan 6

Incyte Corporation (INCY) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest INCY Analyst Ratings & Recommendations

Frequently Asked Questions